Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques

PLoS ONE(2020)10.1371/journal.pone.0228163Source: DataRank Database

Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.63)OA: goldTopics (65)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Margherita Rosati,Alexei Medvedev ORCID,Aaron Scanlan ORCID,Gabrielle Walsh ORCID,Frances Dayton ORCID

Live enrichment

PubMed:32130229 PMC:PMC7055890 OpenAlex:https://openalex.org/W3009139392

National Institutes of Health

Grant: R01 AI118586

National Institutes of Health

Grant: 1R01AI118586-01

Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates

U.S. Food and Drug Administration

National Cancer Institute

FWCI

0.63

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2023

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0228163&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0228163&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0228163

journalhttps://doi.org/10.1371/journal.pone.0228163

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32130229

Fields of Study

HIV Research and TreatmentCytomegalovirus and herpesvirus researchHIV/AIDS Research and Interventions0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Acquired Immunodeficiency SyndromeAnimalsCombined Modality TherapyDisease Models, AnimalDrug Administration ScheduleDrug Therapy, CombinationGenetic VectorsHumansMacaca mulattaPlasmidsRubella virusTime FactorsVaccines, AttenuatedVirus ReplicationSimian Immunodeficiency VirusGene Products, gagSimian Acquired Immunodeficiency SyndromeTreatment OutcomeVirus LatencySAIDS VaccinesAnti-HIV AgentsVaccines, DNASimian immunodeficiency virus

Keywords

VirologyDNA vaccinationRubellaRubella vaccineRhesus macaqueMedicineImmunologyBiologyImmune systemVaccinationImmunizationMeaslesTime FactorsAnti-HIV AgentsScienceGenetic VectorsSimian Acquired Immunodeficiency SyndromeGene Products, gagVaccines, AttenuatedDrug Administration ScheduleVaccines, DNAAnimalsHumansAcquired Immunodeficiency SyndromeQRSAIDS VaccinesCombined Modality TherapyMacaca mulattaDisease Models, AnimalTreatment OutcomeDrug Therapy, CombinationSimian Immunodeficiency VirusRubella virusResearch ArticlePlasmids

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being